Product Images Silodosin
View Photos of Packaging, Labels & Appearance
- Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 01
- Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 02
- Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 03
- Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 04
- Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 05
- Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 06
- image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 07
- image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 08
- image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 09
Product Label Images
The following 9 images provide visual information about the product associated with Silodosin NDC 82619-113 by Creekwood Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 01
Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 02
Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 03
Change from Baseline in IPSS Total Score. The text mentions a significant difference in the IPSS Total Score with a p-value of less than 0.0001 between the placebo group and the group receiving Silodosin Capsules 8 mg over the course of 28 days. The analysis seems to involve the last observation carried forward method.*
Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 04
Change from Baseline in IPSS Total Score comparing Silodosin capsules 8 mg with the Placebo group on Day 357 was statistically significant (p<0.0001).*
Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 05
This text provides information about the change in maximum flow rate (Qmax) in milliliters per second (mL/sec) from baseline to day 84 in a clinical study comparing ArAeh placebo and Silodosin Capsules 8mg. The statistical significance is indicated with *p<0.05. The data is recorded on days 14, 28, and 84 (or last observation carried forward - LOCF).*
Image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 06
image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 07
This is a description of Silodosin capsules, with each capsule containing 4 mg of Silodosin. The recommended dosage is one capsule daily with a meal. The package is child-resistant and should be stored at 20° to 25°C. It is important to protect from light and moisture and dispense in a light-resistant container. The manufacturer is V-Ensure Pharma Technologies Pvt. Ltd. in India, and the distributor is Creekwood Pharmaceuticals LLC in Parsippany, NJ.*
image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 08
This is a description of Silodosin capsules, with each capsule containing Silodosin 8 mg. The usual dosage is one capsule daily with a meal. The packaging is child-resistant and should be stored between 20°C to 25°C. It is important to protect the capsules from light and moisture and keep them in a tight, light-resistant container. This medication is distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ, and manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in Raigad, Maharashtra, India. The package includes 30 capsules and is for prescription use only.*
image - 0fdaf6c9 c861 4894 b4a9 2f6a281998c1 09
This is a prescription-only medication called Silodosin in capsule form, with each capsule containing 8 mg of Silodosin. The usual dosage is one capsule daily with a meal. The packaging is child-resistant and should be stored between 20°C to 25°C. It should be protected from light and moisture and dispensed in a tight, light-resistant container. The medication is manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in Raigad, Maharashtra, India, and distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ. The issue date on this information is 11/2023.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
